The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

Marian Regional Medical Center has successfully completed its 500th Watchman procedure, a milestone in providing advanced treatment options for patients with atrial fibrillation (AFib). The Watchman ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...

CAMBRIA COUNTY, Pa (WJAC) — Conemaugh Memorial Medical Center reached a significant milestone this week by successfully performing their 300th procedure with the "watchman" device. The "watchman left ...

SHREVEPORT, La. (KTAL/KMSS) — CHRISTUS Shreveport-Bossier Health System have announced their 500th successful implant of a breakthrough cardiac procedure that can reduce the risk of a stroke.

Rock Island, Ill.-based Trinity Heart Center recently implanted its 100th Watchman device, ourquadcities.com reported Feb. 17. In 2020, the center became the first and only healthcare provider in the ...

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...

On Saturday, Boston Scientific Corporation (NYSE:BSX) unveiled three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device ...

(Updated) SAN FRANCISCO, California — Preliminary data from the PREVAIL study of the Watchman (AtriTech/Boston Scientific) device for the prevention of stroke and systemic embolism in patients with ...

Under the acquisition, Gore will inherit Conformal’s CLAAS AcuForm system for left atrial appendage closure to mitigate ...

The Watchman left atrial appendage (LAA) closure device (Boston Scientific) is associated with low 1-year stroke rates, despite being used commercially in older, sicker patients than seen in pivotal ...